Dr. Yamamoto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13280 Evening Creek Dr S
Ste 110
San Diego, CA 92128Phone+1 858-546-3800Fax+1 858-546-3900
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiology-Diagnostic, 2013 - 2017
- University of California (San Francisco) School of MedicineInternship, Transitional Year, 2011 - 2012
- David Geffen School of Medicine at UCLAClass of 2011
Certifications & Licensure
- TN State Medical License 2019 - 2026
- HI State Medical License 2019 - 2026
- IA State Medical License 2019 - 2026
- IL State Medical License 2019 - 2026
- NE State Medical License 2019 - 2026
- MT State Medical License 2023 - 2025
- WY State Medical License 2019 - 2025
- American Board of Radiology Diagnostic Radiology
- Join now to see all
Publications & Presentations
PubMed
- 94 citationsBreast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and MetastasisShota Yamamoto, Wonshik Han, Young Woo Kim, Liutao Du, Neema Jamshidi
Radiology. 2015-02-26 - 24 citationsNext Generation Radiologic-Pathologic Correlation in Oncology: Rad-Path 2.0Michael D. Kuo, Shota Yamamoto
AJR. American Journal of Roentgenology. 2011-10-01 - 116 citationsALK Molecular Phenotype in Non–Small Cell Lung Cancer: CT Radiogenomic CharacterizationShota Yamamoto, Ronald L. Korn, Rahmi Oklu, Christopher Migdal, Michael B. Gotway
Radiology. 2014-07-24
Press Mentions
- The Impact of Bronchial Artery Embolisation on the Quality of Life of Patients with Haemoptysis: A Prospective Observational StudyJanuary 6th, 2021
- Impact of the Catechol-O-methyltransferase Val158Met Polymorphism on the Pharmacokinetics of L-dopa and Its Metabolite 3-O-methyldopa in Combination with EntacaponeNovember 2nd, 2020
- The Co-Creator of Prey, Duke Nukem, and Max Payne Wants to Kill You with Vitamin SupplementsOctober 5th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: